2Horsman M R.Measurement of tumor oxyenation[J].Int J Radiat Oncol Biolphys,1998,42(4):701～704.
3Bussink J,Kaanders J H,Van der Kogel A J.Tumor hypoxia at the micro-regional level:clinical relevance and predictive value of expgenous and hypoxic cell narkers[J].Rzdiother Oncol,2003,67(1):3～15.
4Vauoel P,Thews O,Hoeckel M.Treatment resistance of solid tumors:role of hypoxia and anemia[J].Med Oncol,2001,18(4):243～259.
5Brown J M.The hypoxic cell:a target for selective cancer therapy-Eighteenth Bruce F.Cain Memorial Award Lecture[J].Cancer Res,1999,59(23):5 863～5 870.
6Raghunand N,Altbach M I,van Sluis R,et al.Plasmalemmal PH gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P MR spectroscopy[J].Biochem Pharmacol,1999,57(3):309～312.
7Catherine A,Thrash B,Kenneth D T.α HIF:a natural antisense transcript overexpressed in human renal cancer and during hypoxia[J].H Natl Cancer Inst,1999,91(2):143～151.
8Jogi A,Vaiion Christersson J,Holmquist L,et al.Human Neurobiastoma cells exposed to hypoxia:induction of genes associated with gyowth,survival,and aggressive behavior[J].Exp Cell Res,200,295(2):469～487.
